Version 2.1.0.0 CRISP Logo CRISP Homepage Help for CRISP Email Us

Abstract

Grant Number: 5R44AI045249-03
PI Name: ZHU, HENGYI
PI Email: hzhu@strubix.com
PI Title:
Project Title: STRUCTURE BASED DESIGN OF NOVEL INTERLEUKIN-5 RECEPTOR

Abstract: DESCRIPTION: IL-5 is an essential cytokine for the maturation of eosinophil precursors to eosinophils, and it is those eosinophils that have been found to correlate with the severity of the late asthmatic reaction. Thus, design of IL-5 receptor antagonists that block pulmonary eosinophil disorders and present a new approach to treating allergic asthma. In Phase I, we used SBI technology to compute a 3-D dynamic model from the crystal structure of IL-5 and construct pharmacophore templates to screen large scale compound libraries in order to identify potential inhibitors of IL-5 action. Three compounds showing Ki greater than 10 uM in an IL-5 receptor plate assays were obtained. The goal of Phase II is to perform computationally guided synthetic optimizations of active lead compounds identified in Phase I and to discover selective and potent drug candidates active in a murine model for allergic asthma. The long term goal of this project is to develop at least one non-peptide IL-5 receptor antagonist as a potential anti-asthmatic and anti-allergic agent. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Thesaurus Terms:
asthma, computer simulation, cytokine receptor, drug design /synthesis /production, inhibitor /antagonist, interleukin 5, molecular dynamics, protein structure function, structural model
model design /development, receptor binding, respiratory disorder chemotherapy
X ray crystallography, laboratory mouse

Institution: STRUCTURAL BIOINFORMATICS, INC.
10929 TECHNOLOGY PL
SAN DIEGO, CA 92127
Fiscal Year: 2002
Department:
Project Start: 01-SEP-1999
Project End: 31-MAY-2003
ICD: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
IRG: ZRG1


CRISP Homepage Help for CRISP Email Us